Applying RxPONDER to Clinical Practice

Mar 30, 2021
Conference|PER® Miami Breast Cancer Conference

Faculty from the Miami Breast Cancer Conference® discuss how to apply the RxPONDER data to clinical practice.

Faculty from the Miami Breast Cancer Conference® discuss how to apply the RxPONDER data to clinical practice.

Related Videos
View All
Related Content

Improving outcomes in metastatic pancreatic cancer

November 30th 2022

Leone Lays Out Research Needs and Treatment Approaches in Male Breast Cancer

December 1st 2022

Advances in Breast Cancer Treatment Reshape Treatment Paradigms in 2022

November 21st 2022

Oppong Sheds Light on Racial Disparities in Breast Cancer Diagnosis and Mortality

November 17th 2022

Frontline Eganelisib Triplet Provides Potential Long-term PFS Benefit in Metastatic TNBC

November 15th 2022

Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC

November 14th 2022

Improving outcomes in metastatic pancreatic cancer

November 30th 2022

Leone Lays Out Research Needs and Treatment Approaches in Male Breast Cancer

December 1st 2022

Advances in Breast Cancer Treatment Reshape Treatment Paradigms in 2022

November 21st 2022

Oppong Sheds Light on Racial Disparities in Breast Cancer Diagnosis and Mortality

November 17th 2022

Frontline Eganelisib Triplet Provides Potential Long-term PFS Benefit in Metastatic TNBC

November 15th 2022

Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC

November 14th 2022

Improving outcomes in metastatic pancreatic cancer

November 30th 2022

Leone Lays Out Research Needs and Treatment Approaches in Male Breast Cancer

December 1st 2022

Advances in Breast Cancer Treatment Reshape Treatment Paradigms in 2022

November 21st 2022

Oppong Sheds Light on Racial Disparities in Breast Cancer Diagnosis and Mortality

November 17th 2022

Frontline Eganelisib Triplet Provides Potential Long-term PFS Benefit in Metastatic TNBC

November 15th 2022

Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC

November 14th 2022
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights.
All rights reserved.